We are live on ! Find out more
BNR

Burning Rock Biotech
BNR

62 hedge funds and large institutions have $243M invested in Burning Rock Biotech in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

0.09% less ownership

Funds ownership: 3.15% → 3.06% (-0.09%)

27% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 22

28% less funds holding

Funds holding: 86 → 62 (-24)

51% less capital invested

Capital invested by funds: $491M → $243M (-$248M)

63% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 38

Holders
62
Holders Change
-24
Holders Change %
-27.91%
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
14
Increased
16
Reduced
22
Closed
38
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$20.4M
2
AIM
ARK Investment Management
Florida
+$11.6M
3
Millennium Management
Millennium Management
New York
+$4.26M
4
NAMA
Nikko Asset Management Americas
New York
+$3.47M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.13M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$10.2M
2
Ameriprise
Ameriprise
Minnesota
-$9.66M
3
BlackRock
BlackRock
New York
-$7.44M
4
MICM
Matthews International Capital Management
California
-$5.8M
5
O
OrbiMed
New York
-$5.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
76
D.E. Shaw & Co
New York
– -$743K -4,156 Closed
Bank of New York Mellon
77
Bank of New York Mellon
New York
– -$647K -3,617 Closed
Los Angeles Capital Management
78
Los Angeles Capital Management
California
– -$599K -3,351 Closed
DCM
79
Driehaus Capital Management
Illinois
– -$550K -3,078 Closed
RI
80
RTW Investments
New York
– -$536K -3,000 Closed
AAF
81
Andra AP-fonden
Sweden
– -$526K -2,940 Closed
Axa
82
Axa
France
– -$483K -2,700 Closed
PAM
83
Panagora Asset Management
Massachusetts
– -$351K -1,962 Closed
SG Americas Securities
84
SG Americas Securities
New York
– -$326K -1,822 Closed
BCIM
85
British Columbia Investment Management
British Columbia, Canada
– -$325K -1,820 Closed
GGHC
86
Gilder Gagnon Howe & Co
New York
– -$271K -1,516 Closed
Aviva
87
Aviva
United Kingdom
– -$265K -1,480 Closed
Mitsubishi UFJ Trust & Banking
88
Mitsubishi UFJ Trust & Banking
Japan
– -$237K -1,325 Closed
Mitsubishi UFJ Asset Management
89
Mitsubishi UFJ Asset Management
Japan
– -$188K -1,050 Closed
VIA
90
Vident Investment Advisory
Georgia
– -$188K -1,049 Closed
Asset Management One
91
Asset Management One
Japan
– -$125K -704 Closed
Zurich Cantonal Bank
92
Zurich Cantonal Bank
Switzerland
– -$121K -677 Closed
SAM
93
Shell Asset Management
Netherlands
– -$75K -420 Closed
Macquarie Group
94
Macquarie Group
Australia
– -$58K -322 Closed
DekaBank Deutsche Girozentrale
95
DekaBank Deutsche Girozentrale
Germany
– -$428K -265 Closed
Korea Investment Corp
96
Korea Investment Corp
South Korea
– -$30K -170 Closed
GWS
97
Glassman Wealth Services
Virginia
– -$9K -51 Closed
RE
98
RBC Europe
United Kingdom
– -$8.94K -50 Closed
1 2 3
4

BNR Hedge Fund Activity: Q4 2021 in Review

62 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q4 2021, worth a combined $243M — down 51% from $491M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of BNR and 14 opened new positions — a net loss of 24 holders — while 22 trimmed existing stakes and 16 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $20.4M. The largest seller was Jennison Associates, exiting entirely with an estimated $10.2M sold.

  • 62 institutional investors held Burning Rock Biotech (BNR) as of Q4 2021, down from 86 in Q3 2021.
  • Funds reported $243M of Burning Rock Biotech stock for Q4 2021, down 51% quarter-over-quarter.
  • 14 funds opened new Burning Rock Biotech positions in Q4 2021 and 38 closed out, a net change of -24 holders.
  • The largest Burning Rock Biotech buyer in Q4 2021 was Massachusetts Financial Services, an estimated $20.4M added.
  • The largest Burning Rock Biotech seller in Q4 2021 was Jennison Associates, an estimated $10.2M sold.

Based on aggregated 13F filings for Q4 2021.